FGF10 and pulmonary fibrosis: Gupte et al. reported that Fgf10 overexpression during different stages of the bleomycin (BLM) model resulted in a significantly reduced extent of lung fibrosis, suggesting that FGF10 may be a potential candidate for treating pulmonary fibrosis [26].